Open Access

World Malaria Report: time to acknowledge Plasmodium knowlesi malaria

Malaria Journal201716:135

https://doi.org/10.1186/s12936-017-1787-y

Received: 25 January 2017

Accepted: 22 March 2017

Published: 31 March 2017

Abstract

Background

The 2016 World Health Organization (WHO) World Malaria Report documents substantial progress towards control and elimination of malaria. However, major challenges remain. In some regions of Southeast Asia, the simian parasite Plasmodium knowlesi has emerged as an important cause of human malaria, and the authors believe this species warrants regular inclusion in the World Malaria Report.

Main text

Plasmodium knowlesi is the most common cause of malaria in Malaysia, and cases have also been reported in nearly all countries of Southeast Asia. Outside of Malaysia, P. knowlesi is frequently misdiagnosed by microscopy as Plasmodium falciparum or Plasmodium vivax. Thus, P. knowlesi may be underdiagnosed in affected regions and its true incidence underestimated. Acknowledgement in the World Malaria Report of the regional importance of P. knowlesi will facilitate efforts to improve surveillance of this emerging parasite. Furthermore, increased recognition will likely lead to improved delivery of effective treatment for this potentially fatal infection, as has occurred in Malaysia where P. knowlesi case-fatality rates have fallen despite rising incidence. In a number of knowlesi-endemic countries, substantial progress has been made towards the elimination of P. vivax and P. falciparum. However, efforts to eliminate these human-only species should not preclude efforts to reduce human malaria from P. knowlesi. The regional importance of knowlesi malaria was recognized by the WHO with its recent Evidence Review Group meeting on knowlesi malaria to address strategies for prevention and mitigation.

Conclusion

The WHO World Malaria Report has an appropriate focus on falciparum and vivax malaria, the major causes of global mortality and morbidity. However, the authors hope that in future years this important publication will also incorporate data on the progress and challenges in reducing knowlesi malaria in regions where transmission occurs.

Keywords

Plasmodium knowlesi MalariaWorld Malaria ReportMalaysia

Background

The recently released 2016 World Malaria Report, published by the World Health Organization (WHO), documents substantial progress towards control and elimination of malaria [1]. Malaria incidence rate has declined by 41% since 2000, and 21% since 2010. Mortality has fallen by 61% since 2000, and 29% since 2015. Seventeen countries eliminated malaria between 2000 and 2015, with a further 13 countries “approaching elimination.” These data represent significant achievements; however, major challenges remain. Challenges discussed in the World Malaria Report include the development and spread of mosquito resistance to insecticides, resistance to artemisinins and their partner drugs, and funding shortfalls. In Southeast Asia the emerging zoonotic malaria species Plasmodium knowlesi is an additional challenge that warrants regular inclusion in the World Malaria Report.

Main text

Plasmodium knowlesi was reported as a major cause of human malaria in Sarawak, Malaysia, in a seminal paper published 13 years ago [2], and it is now the most common cause of malaria in this country [3, 4]. Cases have been increasingly reported elsewhere in Southeast Asia, including Indonesia, Thailand, Vietnam, and Myanmar, and in returned travellers [5, 6]. In the west of Indonesia, a country with an estimated 1.3 million malaria cases in 2015 [1], emerging evidence suggests that at least in some districts, P. knowlesi may now be the predominant Plasmodium species [7, 8]. In these regions limited evidence suggests that nearly all P. knowlesi cases are diagnosed by microscopy as Plasmodium falciparum or Plasmodium vivax [7, 8]. Thus, under-diagnosis of P. knowlesi may be common and incidence may be significantly underestimated across affected regions.

While mentioned in some previous editions of the World Malaria Report, P. knowlesi is not acknowledged in the 2016 Report. Regular inclusion of knowlesi malaria in the World Malaria Report, and acknowledgment of the importance of P. knowlesi as a cause of human malaria in parts of Southeast Asia, will facilitate efforts to increase recognition and improve surveillance of this emerging parasite.

Plasmodium knowlesi is a highly pathogenic malaria parasite in humans, with a low pyrogenic threshold and a risk of severe disease that in adults appears at least as high as that of P. falciparum [9]. In Malaysia, prior to widespread recognition of P. knowlesi, misdiagnosis of P. knowlesi was associated with delayed administration of parenteral therapy, and high fatality rates were reported [10, 11]. Increased recognition of P. knowlesi has led to more timely delivery of optimal treatment and has likely contributed to the reported sixfold reduction in P. knowlesi case-fatality rates [12].

In the 2016 World Malaria Report, Malaysia is listed as one of 13 countries approaching elimination. Elimination is defined as the interruption of local transmission of a specified malaria parasite in a defined geographic area, and in Malaysia, efforts have focussed on P. vivax and P. falciparum [13]. Indeed, Malaysia has made substantial progress in controlling these species [3, 14], and appears on track to approach elimination of human-only species by 2020. However, efforts to eliminate P. vivax and P. falciparum should not preclude efforts to control P. knowlesi. The WHO Malaria Policy Advisory Committee (MPAC) recognized the regional importance of this species by endorsing the creation of an Evidence Review Group on P. knowlesi, to address key gaps in knowledge and to “advise a path to malaria elimination that includes P. knowlesi” and to develop “appropriate mitigating and preventative strategies” [15]. Such strategies are likely to differ from those used for control of P. vivax and P. falciparum, and further research to increase recognition and identify effective interventions to limit transmission of P. knowlesi is required. The authors welcome the recent convening of the WHO Expert Consultation Meeting on knowlesi malaria, at which these issues were discussed.

Conclusions

The role of the World Malaria Report is to educate and inform, to document progress and identify future challenges for controlling and eliminating malaria. While it is appropriate to focus on falciparum and vivax malaria, the major causes of global mortality and morbidity, the authors hope that in future years this important report will also incorporate data on progress and challenges in controlling knowlesi malaria in those regions where transmission occurs.

Declarations

Authors’ contributions

All authors contributed to the writing of this manuscript. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Funding

BEB and NMA are supported by Fellowships from the National Health and Medical Research Council of Australia.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University
(2)
Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Queen Elizabeth Hospital
(3)
Clinical Research Centre, Queen Elizabeth Hospital
(4)
Jesselton Medical Centre

References

  1. WHO. World Malaria Report 2016. Geneva: World Health Organization; 2016.Google Scholar
  2. Singh B, Sung LK, Matusop A, Radhakrishnan A, Shamsul SSG, Cox-Singh J, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004;363:1017–24.View ArticlePubMedGoogle Scholar
  3. William T, Rahman HA, Jelip J, Ibrahim MY, Menon J, Grigg MJ, et al. Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax malaria in Sabah, Malaysia. PLoS Negl Trop Dis. 2013;7:e2026.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Yusof R, Lau YL, Mahmud R, Fong MY, Jelip J, Ngian HU, Mustakim S, Hussin HM, Marzuki N, Mohd Ali M. High proportion of knowlesi malaria in recent malaria cases in Malaysia. Malar J. 2014;13:168.Google Scholar
  5. Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM. The treatment of Plasmodium knowlesi malaria. Trends Parasitol. 2016;33:242–53.View ArticlePubMedGoogle Scholar
  6. Daneshvar C, William T, Davis TM. Clinical features and management of Plasmodium knowlesi infections in humans. Parasitology. 2017:1–14. doi:10.1017/S0031182016002638.
  7. Herdiana H, Cotter C, Coutrier FN, Zarlinda I, Zelman BW, Tirta YK, et al. Malaria risk factor assessment using active and passive surveillance data from Aceh Besar, Indonesia, a low endemic, malaria elimination setting with Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. Malar J. 2016;15:468.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Lubis IN, Wijaya H, Lubis M, Lubis CP, Divis P, Beshir KB, et al. Contribution of Plasmodium knowlesi to multi-species human malaria infections in North Sumatera, Indonesia. J Infect Dis. 2017. doi:10.1093/infdis/jix091.PubMedGoogle Scholar
  9. Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, et al. A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and P. vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis. 2013;56:383–97.View ArticlePubMedGoogle Scholar
  10. William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, et al. Severe Plasmodium knowlesi malaria in a tertiary hospital, Sabah, Malaysia. Emerg Infect Dis. 2011;17:1248–55.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Rajahram G, Barber BE, William T, Menon J, Anstey NM, Yeo TW. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as P. malariae and delayed parenteral artesunate. Malar J. 2012;11:284.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Rajahram G, Barber B, William T, Grigg MJ, Menon J, Yeo TW, et al. Falling Plasmodium knowlesi malaria death rate among adults despite rising incidence, Sabah, Malaysia, 2010–2014. Emerg Infect Dis. 2016;22:41–8.View ArticlePubMedPubMed CentralGoogle Scholar
  13. WHO. Eliminating malaria. Geneva: World Health Organization; 2016.Google Scholar
  14. William T, Jelip J, Menon J, Anderios F, Mohammad R, Mohammad TA, et al. Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi. Malar J. 2014;13:390.View ArticlePubMedPubMed CentralGoogle Scholar
  15. WHO. Malaria Policy Advisory Committee (MPAC) Meeting: Meeting Report. Geneva: World Health Organization; 2016.Google Scholar

Copyright

© The Author(s) 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement